Key result
OVA-Rha-GLA hydrogels improved the oral bioavailability and anti-inflammatory bioactivities of Licochalcone A compared to control hydrogels in an acute inflammation rat model.
Why the study?
Poor release capability from the matrix and oral bioavailability restrict the oral delivery of licochalcone A in acute inflammation therapy.
OVA-Rha-GLA hydrogels improve the oral bioavailability and anti-inflammatory bioactivities of licochalcone A in an acute inflammation model.
Answers are grounded in this paper and cite their sources.
May support hydrogel optimization for oral delivery; leaves open clinical translation.
Licochalcone A (LA) garnered remarkable acclaim in acute inflammation therapy, however, poor release capability from the matrix and oral bioavailability restrict its oral delivery. To address this challenge, licorice-derived glycyrrhizic acid (GA) and LA were co-assembled into GA-LA (GLA) binary co-assembled Glycyrrhiza nanoparticles (BCGNs), which were subsequently incorporated into supramolecular hydrogel matrix. GLA BCGNs demonstrated a remarkable capacity to scavenge various reactive oxygen species (ROS) and facilitated the cascade process of O 2 •− -H 2 O 2 -O 2 in vitro. Subsequently, GLA was dispersed in nano form into ovalbumin (OVA) and rhamnose (Rha) solutions, which were next self-assembled into OVA-Rha-GLA hydrogels. Remarkably, the introduction of Rha induced disordered secondary conformation of OVA, which decreased its mechanical properties and inherent binding energy, thereby shaping the three-dimensional supramolecular spatial structures of OVA-Rha-GLA networks. The assembly mechanisms indicated that the hydrogen bonding predominantly drove the assembly of loose supramolecular networks surrounded by -OH, -CH 2 and C O bonds on the Rha and OVA. Notably, the conformational transformation facilitated faster LA release, confirmed by computational simulation analysis, which was conducive to acute inflammation curation. Therefore, OVA-Rha-GLA exhibited excellent anti-inflammation and ROS-scavenging versatilities, displaying improved oral bioavailability compared to hydrogels lacking BCGNs or Rha in cellular and animal acute inflammation experiments. The results provided novel BCGNs-embedded supramolecular hydrogel systems to improve the drug release and anti-inflammatory bioactivities of LA, which demonstrated great promise in the management of acute inflammation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Acute inflammation (n=25). OVA-Rha-GLA hydrogels vs. LPS alone, OVA-GLA, OVA-Rha-LA was evaluated on Oral bioavailability and anti-inflammatory markers. OVA-Rha-GLA hydrogels improved the oral bioavailability and anti-inflammatory bioactivities of Licochalcone A compared to control hydrogels in an acute inflammation rat model.
Synapse has enriched 10 related papers. Consider them for comparative context: